Ragasa, Ysrael Edrich M.

HRN: 27-27-35  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2025
CEFOTAXIME 500MG (VIAL)
06/28/2025
07/05/2025
IV
170mg
Q6
Sepsis Neonatorum
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: